FBInvestor
Stocks / Aprea Therapeutics Inc
Institutional Ownership

Aprea Therapeutics Inc

CUSIP 03836J201COM NEWAPREQ1 2026

13D / 13G Filings
10
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
9.9%
Max % of class reported
Institutional Holders
20
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

10 filings · latest Feb 13, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 13, 2026Nantahala Capital Management, LLC13G/A4.5%411.5KSEC
2Nov 17, 2025Lytton Laurence W13G9.9%681.8KSEC
3Nov 12, 2025Sio Capital Management, LLC13G/A1.9%112.2KSEC
4Aug 13, 2025Sio Capital Management, LLC13G/A5.0%279.4KSEC
5May 14, 2025Stonepine Capital Management, LLC13G/A4.3%SEC
6Apr 8, 2025Sio Capital Management, LLC13G/A5.0%276.6KSEC
7Feb 13, 2025Stonepine Capital Management, LLC13G/A5.1%SEC
8Nov 14, 2024Nantahala Capital Management, LLC13G7.3%411.5KSEC
9Oct 10, 2024Stonepine Capital Management, LLC13G6.6%365.4KSEC
10Feb 14, 2024Sio Capital Management, LLC13G7.5%280.0KSEC

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →